Sotalol Hydrochloride Tablet
Product Images NDC 55154-8179

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sotalol Hydrochloride (NDC 55154-8179). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

17f2a6ca B6eb 4025 8ae0 A3d928f2fadc 00

This is a package of Sotalol hydrochloride tablets, with each tablet containing 80 mg of the active ingredient. The product labeling provides dosage instructions, precautions, and storage details. The package is not child-resistant and is intended for institutional use only. Outpatient use requires a child-resistant container. The medication inside the package was produced by Apotex Corp and distributed by American Health Packaging, an AmeriSource Bergen company, with a location in Columbus, Ohio.*

FDA Label Image

8a0b7575 7f90 9404 E053 2a95a90a002f

FDA Label Image

Figure 1

FDA Label Image

Figure 2

The text describes the Recurrence-Free Survival rate of patients who took Oral Sotalol at different doses (80 mg, 120 mg, and 160 mg) compared to those who took a placebo. The P-values (indicating the statistical significance of the results) were calculated using the Log-Rank statistical test. The table shows that patients who took the 120 mg and 160 mg doses of Oral Sotalol had significantly better Recurrence-Free Survival rates than those who took a placebo, with P-values of 0.018 and 0.029, respectively. The information is accompanied by a graph that shows the Recurrence-Free Survival rate over time (in days) for each treatment group.*

FDA Label Image

Figure1.jpg (Image 01)

FDA Label Image

Image 02

This appears to be a graph showing the Recurrence-Free Survival rates for Sotalol Hydrochloride AF compared to Placebo over a period of 180 days. The x-axis represents the time in days while the y-axis represents the survival rate. Sotalol Hydrochloride AF shows a higher survival rate compared to Placebo.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.